Align Technology (ALGN)
(Delayed Data from NSDQ)
$241.35 USD
+4.38 (1.85%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $241.74 +0.39 (0.16%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$241.35 USD
+4.38 (1.85%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $241.74 +0.39 (0.16%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Zacks News
Abbott (ABT) Q2 Earnings Beat, Molecular Diagnostic Sales Drop
by Zacks Equity Research
Abbott's (ABT) Adult Nutrition sales benefit from improved sales performance of complete and balanced nutrition brand Ensure and diabetes nutrition brand, Glucerna in Q2.
Align Technology (ALGN) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Continued adoption of Invisalign Clear Aligners and iTero scanners are expected to have contributed to the Align Technology's (ALGN) second-quarter 2021 results.
Buy These 2 Growth Stocks Before Earnings and Hold for Years?
by Benjamin Rains
Here are two strong growth-focused stocks poised to thrive for years that investors might want to consider buying around their Q2 earnings reports...
Align Technology (ALGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nevro's (NVRO) Senza System Approved by FDA for PDN Treatment
by Zacks Equity Research
Nevro's (NVRO) 10 kHz SCS treatment, which has received the FDA nod for treating patients with PDN, is expected to provide sustained pain relief as well as improve health-related quality of life.
Nevro (NVRO) Reports Impressive Preliminary Q2 Revenues
by Zacks Equity Research
Improvement in Nevro's (NVRO) second-quarter revenues is likely to have resulted from a solid product portfolio.
Neogen (NEOG) Misses Q4 Earnings, Tops Revenue Estimates
by Zacks Equity Research
Strong segmental revenues and solid international performance across Neogen's (NEOG) entire business drove its topline.
Intuitive Surgical (ISRG) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Intuitive Surgical's (ISRG) second-quarter results reflect strong segmental performance.
Masimo (MASI) Boosts Its Product Suite With Latest Release
by Zacks Equity Research
Masimo's (MASI) latest offering is expected to improve patient care due to its re-engineered integration design.
Cerner (CERN) Extends Partnership to Accelerate Digital Health
by Zacks Equity Research
Cerner (CERN) expands its partnership with Baystate Health by launching a digital health platform to boost consumer-focused care.
Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about Veeva Systems (VEEV) on its slew of partnerships and robust product adoptions.
Catalent (CTLT) Inks Deal for Feasibility Study of CBD Product
by Zacks Equity Research
Catalent's (CTLT) latest agreement is expected to lead to a prototype development of a Zydis formulation via a feasibility study.
3 Stocks to Tap the Promising Dental Supplies Industry
by Trina Mukherjee
Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
AngioDynamics (ANGO) Q4 Earnings Match Estimates, Revenues Top
by Zacks Equity Research
AngioDynamics (ANGO) registers strong revenue growth across all its GBUs in fiscal 2021 Q4.
Stryker (SYK) Unveils Tornier Shoulder Arthroplasty Portfolio
by Zacks Equity Research
Stryker (SYK) introduces new Tornier shoulder arthroplasty portfolio enabling the company to strengthen its position in the shoulder market.
Here's Why You Should Retain Change Healthcare (CHNG) Stock
by Zacks Equity Research
Change Healthcare (CHNG) continues to benefit from robust payment accuracy business. However, intense competition remains a woe.
3 Stocks in Focus on Evolving MedTech Trends Amid COVID-19
by Riya Anand
Stocks like Allscripts Healthcare Solutions (MDRX), National Vision Holdings (EYE) and Quest Diagnostics (DGX) are in focus on evolving MedTech trends.
Here's Why You Should Retain Intuitive Surgical (ISRG) Stock
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System.
Bear of the Day: SmileDirectClub, Inc. (SDC)
by Benjamin Rains
SmileDirectClub has largely struggled since its September 2019 IPO and its EPS revisions have trended in the wrong direction...
Smith+Nephew's (SNN) New Device to Boost Patient Outcomes
by Zacks Equity Research
Smith+Nephew's (SNN) FAST-FLIX FLEX Meniscal Repair System to provide long-term benefits to patients.
Here's Why You Should Retain Merit Medical (MMSI) Stock Now
by Zacks Equity Research
Merit Medical (MMSI) continues to gain traction from robust Peripheral Intervention arm and solid international presence. Forex, although, remains a concern.
What Makes Align Technology (ALGN) a Solid Choice Right Now?
by Zacks Equity Research
Strong performance and latest innovations in the Invisalign and iTero family are driving the top line for Align Technology (ALGN).
Has Align Technology (ALGN) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ALGN) Outperforming Other Medical Stocks This Year?
Dental Space Gains Momentum in 2021: 4 Stocks to Invest in
by Debanjana Dey
Dental stocks like Henry Schein (HSIC), Align Technology (ALGN), Straumann Holding (SAUHF) and DENTSPLY SIRONA (XRAY) are expected to continue their run over the next few months.
Align Technology (ALGN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Align Technology (ALGN) closed at $612.22, marking a +1.25% move from the previous day.